The Possibility of Acute Drug-Induced Liver Injury Associated With Prednisolone

被引:0
作者
Okano, Hiroshi [1 ]
Takagi, Mikio [2 ]
Mukai, Katsumi [1 ]
Nishimura, Akira [1 ]
Asakawa, Kana [3 ]
Baba, Youichirou [3 ]
Murata, Tetsuya [3 ]
机构
[1] Suzuka Gen Hosp, Gastroenterol, Suzuka, Japan
[2] Suzuka Gen Hosp, Radiol, Suzuka, Japan
[3] Suzuka Gen Hosp, Pathol, Suzuka, Japan
关键词
corticosteroid-induced liver damage; drug-induced lymphocyte-stimulation test; low-dose corticosteroid therapy; prednisolone; drug-induced liver injury; METHYLPREDNISOLONE; HEPATOTOXICITY; PATIENT;
D O I
10.7759/cureus.54227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A female patient was referred to our hospital with complaints of liver injury. She had been treated for immunoglobulin (Ig)A nephropathy using prednisolone and other medications. Drug-induced liver injury (DILI) was suspected, as no evidence of viral infection or autoimmune liver disease was apparent. All medications except for prednisolone were discontinued, but liver enzyme levels remained elevated. Percutaneous liver biopsy showed the characteristics of DILI and drug lymphocyte stimulation testing yielded positive results for prednisolone. After stopping administration of prednisolone, liver enzyme levels recovered to near-normal. Prednisolone has immunosuppressive effects and is sometimes used to treat DILI. Some reports have revealed that high-dose corticosteroids can induce liver injury, but liver injuries associated with low-dose corticosteroid therapy have not been described. Prednisolone-induced liver injury is a rare phenomenon. When low-dose corticosteroids are used for treatment, care should be taken regarding the possibility of liver injury.
引用
收藏
页数:7
相关论文
共 18 条
[1]   Review article: drug-induced liver injury in clinical practice [J].
Bjornsson, E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (01) :3-13
[2]  
Eriksson C, 2011, J GASTROINTEST LIVER, V20, P77
[3]  
Farrell GC, 2002, SEMIN LIVER DIS, V22, P109
[4]   Recurrent High-Dose Intravenous Methylprednisolone Succinate Pulse Therapy-Induced Hepatopathy in a Patient with Multiple Sclerosis [J].
Furutama, Daisuke ;
Kimura, Fumiharu ;
Shinoda, Keiichi ;
Maeda, Tamaki ;
Tanaka, Toshifumi ;
Ohsawa, Nakaaki .
MEDICAL PRINCIPLES AND PRACTICE, 2011, 20 (03) :291-293
[5]   Successful treatment of erlotinib-induced acute hepatitis and acute interstitial pneumonitis with high-dose corticosteroid: a case report and literature review [J].
Lai, Y. -C. ;
Lin, P. -C. ;
Lai, J. -I. ;
Hsu, S. -Y. ;
Kuo, L. -C. ;
Chang, S. -C. ;
Wang, W. -S. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (07) :461-466
[6]   Epidemiology and individual susceptibility to adverse drug reactions affecting the liver [J].
Larrey, D .
SEMINARS IN LIVER DISEASE, 2002, 22 (02) :145-155
[7]   Hepatotoxicity After High-Dose Methylprednisolone for Demyelinating Disease [J].
Loraschi, Anna ;
Banfi, Paola ;
Mauri, Marco ;
Sessa, Fausto ;
Bono, Giorgio ;
Cosentino, Marco .
CLINICAL NEUROPHARMACOLOGY, 2010, 33 (01) :52-54
[8]   Current concepts - Drug-related hepatotoxicity [J].
Navarro, VJ ;
Senior, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :731-739
[9]   Changing etiologies and outcomes of acute liver failure: A perspective from Japan [J].
Oketani, Makoto ;
Ido, Akio ;
Tsubouchi, Hirohito .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 :65-71
[10]  
Fernández MR, 2008, REV ESP ENFERM DIG, V100, P720, DOI 10.4321/s1130-01082008001100010